Notes to the Consolidated Financial Statements continued

for the year ended 31 December 2007

28 Additional disclosures on financial instruments

Measurement of financial instruments by category

    Book amount
  Amortised cost
  Fair value recognised in equity
  Fair value recognised in P&L account
At 31 December 2007   €m   €m   €m   €m
Assets                
Other financial assets:                
Derivative hedging instruments (held for trading)   4.6     4.6  
Derivative non-hedging instruments
(held for trading)
  9.4       9.4
Cash and short-term deposits   60.9   60.9    
Trade and other receivables   1,391.8   1,391.8    
    1,466.7   1,452.7   4.6   9.4
Liabilities and shareholders’ equity:                
Other financial liabilities:                
Derivative hedging instruments (held for trading)   (53.5)     (9.4)   (44.1)
Derivative non-hedging instruments
(held for trading)
  (1.3)       (1.3)
Bank overdrafts   (8.8)   (8.8)    
Bank loans and other loans   (150.0)   (150.0)    
Commercial paper   (22.2)   (22.2)    
Loan notes   (549.2)   (549.2)    
Obligations under finance leases   (273.7)   (273.7)    
Deferred consideration   (30.6)   (30.6)    
Trade and other payables   (670.3)   (670.3)    
    (1,759.6)   (1,704.8)   (9.4)   (45.4)
    Book amount
  Amortised cost
  Fair value recognised in equity
  Fair value recognised in P&L account
At 31 December 2006   €m   €m   €m   €m
Assets                
Other financial assets:                
Derivative hedging instruments
(held for trading)
  1.0     1.0  
Derivative non-hedging instruments
(held for trading)
  10.3       10.3
Cash and short-term deposits   116.6   116.6    
Trade and other receivables   1,358.6   1,358.6    
    1,486.5   1,475.2   1.0   10.3
Liabilities and shareholders’ equity:                
Other financial liabilities:                
Derivative hedging instruments (held for trading)   (72.5)     (7.9)   (64.6)
Derivative non-hedging instruments
(held for trading)
  (1.1)       (1.1)
Bank overdrafts   (3.3)   (3.3)    
Bank loans and other loans   (7.1)   (7.1)    
Commercial paper        
Loan notes   (780.5)   (780.5)    
Obligations under finance leases   (292.1)   (292.1)    
Deferred consideration   (33.0)   (33.0)    
Trade and other payables   (672.6)   (672.6)    
    (1,862.2)   (1,788.6)   (7.9)   (65.7)

The fair value of the above items recognised at amortised cost is as below:

Summary of fair values of non-derivative financial assets and liabilities

  2007   2006
  Book amount
€m
  Fair value
€m
  Book amount as restated1
€m
  Fair value as restated1
€m
Fair value of financial assets and financial liabilities:              
Non-current assets – available for sale investments (see Note 15) 0.6   0.6   0.7   0.7
Trade and other receivables (see Note 19) 1,391.8   1,391.8   1,358.6   1,358.6
Current assets – held for trading (see Note 15) 5.4   5.4   22.6   22.6
Cash and cash equivalents (see Note 20) 60.9   60.9   116.6   116.6
Trade and other payables (see Note 21) (670.3)   (670.3)   (672.6)   (672.6)
Obligations under finance leases (see Note 24) (273.7)   (273.7)   (292.1)   (292.1)
Financial liabilities – borrowings:              
– Current (see Note 25) (31.0)   (31.0)   (231.7)   (226.1)
– Non-current (see Note 25) (699.2)   (657.1)   (559.2)   (512.3)
Financial liabilities – deferred consideration:              
– Current (see Note 25) (0.3)   (0.3)   (0.3)   (0.3)
– Non-current (see Note 25) (30.3)   (28.8)   (32.7)   (35.5)
               

The Directors consider that the book value of non-current assets – available-for-sale investments; trade and other receivables; current assets – held for trading; cash and cash equivalents; and trade and other payables, approximate to their fair value.

The fair value of obligations under finance leases approximates to their book value as the majority of these obligations are due within one year (see Note 24).

The fair value of borrowings and deferred consideration for disclosure purposes is estimated by discounting the future contractual cash flows at the current market interest rate that is available to the Group for similar financial instruments.